Market Consultation on the Methodology Change of the North American Medical Marijuana Index

Frankfurt, 10 July 2017 – Solactive has decided to conduct a Market Consultation with regard to its Oversight Comitee’s proposal to change the methodology of the North American Medical Marijuana Index. All stakeholders and interested third parties are invited to provide input and feedback to the proposed Policy. Solactive welcomes all contributions and thoroughly assesses all responses received. The overarching aim is to maintain the integrity and continued comparability of the index while mitigating certain effects of the weighting scheme perceived as negative.

If you would like to share your thoughts with Solactive, please use this consultation form and provide us with your personal details and those of your organization.